Thomas Wakim
Stock Analyst at Bell Potter
(0.33)
# 4,571
Out of 5,125 analysts
120
Total ratings
47.1%
Success rate
-8%
Average return
Main Sectors:
Stocks Rated by Thomas Wakim
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ASX: NEU Neuren Pharmaceuticals Limited | Reiterated: Buy | $25.50 → $26.50 | $24.05 | +10.19% | 18 | Nov 5, 2026 | |
| ASX: ATX Amplia Therapeutics Limited | Reiterated: Buy | $0.42 | $0.09 | +388.37% | 4 | Nov 3, 2026 | |
| ASX: ALC Alcidion Group Limited | Reiterated: Buy | $0.15 | $0.11 | +36.36% | 17 | Nov 2, 2026 | |
| ASX: CGS Cogstate Limited | Reiterated: Buy | $3.70 → $4.05 | $3.64 | +11.42% | 8 | Oct 19, 2026 | |
| ASX: PYC PYC Therapeutics Limited | Reiterated: Buy | $3.00 → $3.30 | $1.92 | +72.10% | 10 | Oct 7, 2026 | |
| ASX: IMM Immutep Limited | Reiterated: Hold | $0.07 → $0.06 | $0.03 | +140.00% | 9 | Sep 14, 2026 | |
| ASX: CUV Clinuvel Pharmaceuticals Limited | Downgraded: Hold | $17.00 → $11.50 | $7.57 | +52.02% | 6 | Aug 27, 2026 | |
| ASX: CSL CSL Limited | Reiterated: Hold | $120.00 → $150.00 | $201.52 | -25.57% | 11 | Aug 19, 2026 | |
| ASX: SNT Syntara Limited | Reiterated: Buy | $0.06 | $0.02 | +275.00% | 7 | Jul 28, 2026 | |
| ASX: MAP Microba Life Sciences Limited | Downgraded: Hold | $0.12 → $0.05 | $0.04 | +38.89% | 13 | Jul 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $0.55 → $0.10 | $0.07 | +38.89% | 8 | Apr 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $0.09 → $0.10 | $0.01 | n/a | 5 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $1.30 → $0.05 | $0.01 | n/a | 4 | Apr 1, 2025 |
Neuren Pharmaceuticals Limited
Nov 5, 2026
Reiterated: Buy
Price Target: $25.50 → $26.50
Current: $24.05
Upside: +10.19%
Amplia Therapeutics Limited
Nov 3, 2026
Reiterated: Buy
Price Target: $0.42
Current: $0.09
Upside: +388.37%
Alcidion Group Limited
Nov 2, 2026
Reiterated: Buy
Price Target: $0.15
Current: $0.11
Upside: +36.36%
Cogstate Limited
Oct 19, 2026
Reiterated: Buy
Price Target: $3.70 → $4.05
Current: $3.64
Upside: +11.42%
PYC Therapeutics Limited
Oct 7, 2026
Reiterated: Buy
Price Target: $3.00 → $3.30
Current: $1.92
Upside: +72.10%
Immutep Limited
Sep 14, 2026
Reiterated: Hold
Price Target: $0.07 → $0.06
Current: $0.03
Upside: +140.00%
Clinuvel Pharmaceuticals Limited
Aug 27, 2026
Downgraded: Hold
Price Target: $17.00 → $11.50
Current: $7.57
Upside: +52.02%
CSL Limited
Aug 19, 2026
Reiterated: Hold
Price Target: $120.00 → $150.00
Current: $201.52
Upside: -25.57%
Syntara Limited
Jul 28, 2026
Reiterated: Buy
Price Target: $0.06
Current: $0.02
Upside: +275.00%
Microba Life Sciences Limited
Jul 16, 2026
Downgraded: Hold
Price Target: $0.12 → $0.05
Current: $0.04
Upside: +38.89%
Apr 7, 2026
Downgraded: Hold
Price Target: $0.55 → $0.10
Current: $0.07
Upside: +38.89%
May 13, 2025
Reiterated: Hold
Price Target: $0.09 → $0.10
Current: $0.01
Upside: n/a
Apr 1, 2025
Downgraded: Sell
Price Target: $1.30 → $0.05
Current: $0.01
Upside: n/a